查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
非霍奇金淋巴瘤治疗全球市场规模研究与预测：按疾病类型、分销渠道和地区分析，2022-2029 年
市场调查报告书
商品编码
1251575

非霍奇金淋巴瘤治疗全球市场规模研究与预测：按疾病类型、分销渠道和地区分析，2022-2029 年

Global Non - Hodgkin Lymphoma Therapeutics Market Size study & Forecast, by Type of Therapy by Disease Type, by Distribution Channel and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球非霍奇金淋巴瘤治疗市场价值约为 83.3 亿美元，预计在 2022-2029 年预测期内将以约 8.50% 的健康增长率增长。

非霍奇金淋巴瘤（NHL）是一种在人体内产生异常淋巴细胞的疾病。除非接受治疗，否则这些淋巴细胞不会死亡并会在体内继续生长和分裂。NHL 通常始于淋巴结，但如果不及时治疗，可以扩散到整个淋巴系统。非霍奇金淋巴瘤治疗市场根据类型、治疗类型、给药途径、分销渠道和最终用户进行细分。行业的市场增长从这些细分市场的增长中进行检查，并帮助用户为您提供市场洞察力的概述，并做出对核心市场应用程序进行分类的决策。

非霍奇金淋巴瘤事件的增加导致市场增长，目前几乎所有类型癌症（包括某些类型的非霍奇金淋巴瘤）的高患病率趋势都是难治性或恶化的。需要更好的临床和挽救结果非霍奇金淋巴瘤患者是一个重要的驱动因素。在开发针对多种类型的非霍奇金淋巴瘤的有效治疗方法方面，持续不断地加大研发力度是主要驱动力之一。市场参与者增加投资也是长期增长的一个因素。对口服药物的需求不断增长也促进了大多数产品以胶囊或片剂形式提供的市场的增长。

新兴市场批准疗法的成本上升限制了先进疗法的采用。非霍奇金淋巴瘤治疗市场的增长是由某些类型的治疗（如免疫疗法）的高成本推动的。在预测期内，缺乏对非霍奇金淋巴瘤治疗不了解的训练有素的专业人员可能会抑制全球非霍奇金淋巴瘤市场的增长。

此外，公众健康意识的提高也极大地推动了市场的增长。据美国癌症协会称，估计有 80,470 人患有非霍奇金淋巴瘤。发病率最高的似乎是女性 80-84 岁和男性 85-89 岁之间的年龄组。对更好的临床实践以有效治疗患者的不断增长的需求正在推动市场增长。

全球非霍奇金淋巴瘤治疗市场研究考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。北美由于其对所有形式癌症（包括非霍奇金淋巴瘤等各种血液癌症）的高患病率和认识而占据市场主导地位。因此，非霍奇金淋巴瘤正在接受昂贵的疗法，例如免疫疗法。在预测期内，亚太地区将成为增长最快的市场。日本位于亚太地区，人口众多，批准了 Kimia 等昂贵的治疗药物，这有助于亚太市场的增长。

目录

第一章执行摘要

  • 市场快照
  • 2019-2029 年按细分市场的全球市场估计和预测
    • 2019-2029 年按地区分列的非霍奇金淋巴瘤治疗市场
    • 非霍奇金淋巴瘤治疗市场，按疗法，2019-2029
    • 非霍奇金淋巴瘤治疗市场，按疾病分类，2019-2029
    • 非霍奇金淋巴瘤治疗市场，按分布，2019-2029
  • 主要趋势
  • 调查方法
  • 调查先决条件

第二章全球非霍奇金淋巴瘤治疗市场定义和范围

  • 研究目标
  • 市场定义和范围
    • 调查范围
    • 产业进化
  • 本次调查涵盖的年份
  • 货币兑换率

第三章非霍奇金淋巴瘤药物的全球市场动态

  • 非霍奇金淋巴瘤药物市场影响分析（2019-2029）
    • 市场驱动力
      • 市场参与者增加投资
      • 对口服药物的需求不断增长
    • 市场挑战
      • 关于非霍奇金淋巴瘤的高昂治疗费用
    • 市场机会
      • 非霍奇金淋巴瘤增加
      • 保健意识不断增强

第四章非霍奇金淋巴瘤治疗的全球市场行业分析

  • 波特五力模型
    • 供应商的议价能力
    • 买方议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争对手之间的竞争
  • 波特五力模型的未来方法（2019-2029）
  • PEST分析
    • 政治的
    • 经济的
    • 社会的
    • 技术的
  • 招商引资模式
  • 分析师的建议和结论
  • 最佳投资机会
  • 关键成功策略

第 5 章风险评估 COVID-19 影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

6 非霍奇金淋巴瘤治疗的全球市场，按疗法

  • 市场快照
  • 全球非霍奇金淋巴瘤治疗药物市场：按疗法、按性能 - 潜力分析
  • 2019-2029 年全球非霍奇金淋巴瘤药物市场按疗法估计和预测
  • 非霍奇金淋巴瘤治疗市场，细分分析
    • 化学处理
    • 靶向治疗
    • 免疫疗法
    • 其他

7 非霍奇金淋巴瘤治疗的全球市场，按疾病类型

  • 市场快照
  • 非霍奇金淋巴瘤疗法的全球市场：按疾病类型进行的性能潜力分析
  • 2019-2029 年按疾病类型分列的全球非霍奇金淋巴瘤药物市场估计和预测
  • 非霍奇金淋巴瘤治疗市场，细分分析
    • B细胞淋巴瘤
    • T细胞淋巴瘤

8 全球非霍奇金淋巴瘤治疗市场，按分销渠道

  • 市场快照
  • 非霍奇金淋巴瘤治疗药物的全球市场：按分销渠道进行的性能潜力分析
  • 2019-2029 年按分销渠道分列的全球非霍奇金淋巴瘤药物市场估计和预测
  • 非霍奇金淋巴瘤治疗市场，细分分析
    • 医院药房
    • 零售药店
    • 其他

9 非霍奇金淋巴瘤治疗的全球市场：区域分析

  • 非霍奇金淋巴瘤治疗市场，按地区划分的市场概况
  • 北美
    • 美国
      • 2019-2029 年各疗法的估计和预测
      • 2019-2029 年各疾病类型的估计和预测
      • 2019-2029 年各分销渠道的估计和预测
    • 加拿大
  • 欧洲非霍奇金淋巴瘤药物市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 亚太非霍奇金淋巴瘤药物市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 拉丁美洲非霍奇金淋巴瘤药物市场概况
    • 巴西
    • 墨西哥
  • 世界其他地区

第 10 章 竞争信息

  • 顶级市场战略
  • 公司简介
    • Takeda Pharmaceutical Company Limited
      • 主要信息
      • 概述
      • 财务（仅当数据可用时）
      • 产品概要
      • 最近的发展
    • AstraZeneca plc
    • Bayer AG
    • Novartis AG
    • Kyowa Kirin Co. Ltd.
    • Bristol Myers Squibb Company
    • Janssen Pharmaceuticals Inc.
    • Merck & Co. Inc.
    • Sanofi India
    • AbbVie. Inc

第十一章调查过程

  • 调查过程
    • 数据挖掘
    • 分析
    • 市场估计
    • 验证
    • 出版物
  • 调查特点
  • 调查先决条件

Global Non - Hodgkin Lymphoma Therapeutics Market is valued at approximately USD 8.33 billion in 2021 and is anticipated to grow with a healthy growth rate of around 8.50% over the forecast period 2022-2029. Non- Hodgkin lymphoma (NHL) is a condition where abnormal lymphocytes are produced in the human body. These lymphocytes do not die and keep growing and dividing within the body unless treated. NHL is generally located at lymph nodes, however, if not treated in time, then it might spread to the entire lymphatic system. The Non- Hodgkin lymphoma therapeutics market is subdivided on basis of type, treatment type, route of administration, distribution channel and end user. The market growth of industries will get inspected from the growth of these segments and help the users to overview you the market insights and helps to make decisions for classifying core market application.

Increasing events of Non-Hodgkin Lymphomas lead to Market Growth and are the current trends of higher prevalence of almost all types of cancer which also includes several types of NHL The need for better clinical and remedial results for the patients for non-Hodgkin lymphoma where the disease has become refractory or deteriorated is a critical driving factor. Ongoing and increased R&D activity in the development of efficient therapeutics for a number of types of NHL are one of the key driving factors. Along with an increasing investment by market players also a factor for long term growth. The rising demand for oral drugs has also contributed to the market growth where most products are available in capsule and tablet form.

Increased cost of approved Therapeutics in Emerging countries leads to curb the Adoption of advanced Therapeutics. The non-Hodgkin lymphoma treatment market growth is affected by the high cost imputed to certain types of therapies like immunotherapies. Lack of trained professionals who are unaware of the knowledge of the treatment methods for this disease could curb the growth of the global non-Hodgkin lymphoma market over a forecast period.

As Health Awareness increasing among the population also indicates a major boost to the market growth. According to the American Cancer Society, non-Hodgkin lymphoma is estimated to be around 80, 470. The Highest rates are likely to be in the age group between 80-84 years for females and 85-89 years for males. The need for better clinical are required more and more to treat the patients effectively which drives the market growth.

The key regions considered for the Global Non - Hodgkin Lymphoma Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominates the market due to high prevalence and awareness of all forms of cancer including various blood cancers such as non-Hodgkin's lymphoma. These led to adoption of expensive form of therapies for treatment of NHL such as immunotherapies. Asia Pacific is going to be the fastest growing market in the forecasted period, Japan in Asia Pacific has approved the expensive therapeutics such as KYMRIAH which holds strong population base and well contribute in the Asia Pacific market growth.

Major market players included in this report are:

  • Takeda Pharmaceutical Company Limited
  • AstraZeneca plc
  • Bayer AG
  • Novartis AG
  • Kyowa Kirin Co. Ltd.
  • Bristol Myers Squibb Company
  • Janssen Pharmaceuticals Inc.
  • Merck & Co., Inc.
  • Sanofi India
  • AbbVie Inc.

Recent Developments in the Market:

  • April 2021 - Kyowa Kirin Co., Ltd. and MEI Pharma Inc. announced the completion of patient enrollment in the global Phase 2 TIDAL study in the primary efficacy follicular lymphoma population.
  • April 2021 - Kyowa Kirin Co., Ltd. and MEI Pharma Inc. announced the completion of patient enrollment in the gl primary efficacy population for follicular lymphoma. * February 2021 - Bristol-Myers Squibb Company Receives FDA Approval of CAR T-Cell Therapy Breyanzi for the Treatment of Large B-Cell Lymphoma in Patients Who Relapsed After Two Other Systematic Treatments or Responded to Previous Therapy announced that it had received Treatment has not been addressed.
  • December 2020 - AstraZeneca announced that Calquence, an anti-cancer drug used to treat patients with mantle cell lymphoma, has shown positive responses in a Phase 2 clinical trial.

Global Non - Hodgkin Lymphoma Therapeutics Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered By Therapy, Disease Type, Distribution channel, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapy:

  • Immunotherapy
  • Targeted Therapy
  • Chemotherapy
  • Others

By Disease Type:

  • B-cell Lymphoma
  • T-cell Lymphoma

By Distribution Channel:

  • Hospitals
  • Retail Pharmacies
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Non-Hodgkin lymphoma treatment Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Non-Hodgkin lymphoma treatment Market, by Therapy, 2019-2029 (USD Billion)
    • 1.2.3. Non-Hodgkin lymphoma treatment Market, by Disease, 2019-2029 (USD Billion)
    • 1.2.4. Non-Hodgkin lymphoma treatment Market, by Distribution, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Non-Hodgkin lymphoma treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Non-Hodgkin lymphoma treatment Market Dynamics

  • 3.1. Non-Hodgkin lymphoma treatment Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing investments by Market players
      • 3.1.1.2. Rising Demand for oral drugs
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Non-Hodgkin lymphoma treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increase in Non-Hodgkin Lymphoma
      • 3.1.3.2. Rising Healthcare Awareness

Chapter 4. Global Non-Hodgkin lymphoma treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Non-Hodgkin lymphoma treatment Market, by Therapy

  • 6.1. Market Snapshot
  • 6.2. Global Non-Hodgkin lymphoma treatment Market by Therapy, Performance - Potential Analysis
  • 6.3. Global Non-Hodgkin lymphoma treatment Market Estimates & Forecasts by Therapy 2019-2029 (USD Billion)
  • 6.4. Non-Hodgkin lymphoma treatment Market, Sub Segment Analysis
    • 6.4.1. Chemotherapy
    • 6.4.2. Targeted Therapy
    • 6.4.3. Immunotherapy
    • 6.4.4. Others

Chapter 7. Global Non-Hodgkin lymphoma treatment Market, by Disease type

  • 7.1. Market Snapshot
  • 7.2. Global Non-Hodgkin lymphoma treatment Market by Disease type, Performance - Potential Analysis
  • 7.3. Global Non-Hodgkin lymphoma treatment Market Estimates & Forecasts by Disease type 2019-2029 (USD Billion)
  • 7.4. Non-Hodgkin lymphoma treatment Market, Sub Segment Analysis
    • 7.4.1. B-Cell Lymphoma
    • 7.4.2. T-cell Lymphoma

Chapter 8. Global Non-Hodgkin lymphoma treatment Market, by Distribution channel

  • 8.1. Market Snapshot
  • 8.2. Global Non-Hodgkin lymphoma treatment Market by Distribution channel, Performance - Potential Analysis
  • 8.3. Global Non-Hodgkin lymphoma treatment Market Estimates & Forecasts by Distribution channel 2019-2029 (USD Billion)
  • 8.4. Non-Hodgkin lymphoma treatment Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacies
    • 8.4.2. Retail pharmacies
    • 8.4.3. Others

Chapter 9. Global Non-Hodgkin lymphoma treatment Market, Regional Analysis

  • 9.1. Non-Hodgkin lymphoma treatment Market, Regional Market Snapshot
  • 9.2. North America Non-Hodgkin lymphoma treatment Market
    • 9.2.1. U.S. Non-Hodgkin lymphoma treatment Market
      • 9.2.1.1. Therapy breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Disease type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Non-Hodgkin lymphoma treatment Market
  • 9.3. Europe Non-Hodgkin lymphoma treatment Market Snapshot
    • 9.3.1. U.K. Non-Hodgkin lymphoma treatment Market
    • 9.3.2. Germany Non-Hodgkin lymphoma treatment Market
    • 9.3.3. France Non-Hodgkin lymphoma treatment Market
    • 9.3.4. Spain Non-Hodgkin lymphoma treatment Market
    • 9.3.5. Italy Non-Hodgkin lymphoma treatment Market
    • 9.3.6. Rest of Europe Non-Hodgkin lymphoma treatment Market
  • 9.4. Asia-Pacific Non-Hodgkin lymphoma treatment Market Snapshot
    • 9.4.1. China Non-Hodgkin lymphoma treatment Market
    • 9.4.2. India Non-Hodgkin lymphoma treatment Market
    • 9.4.3. Japan Non-Hodgkin lymphoma treatment Market
    • 9.4.4. Australia Non-Hodgkin lymphoma treatment Market
    • 9.4.5. South Korea Non-Hodgkin lymphoma treatment Market
    • 9.4.6. Rest of Asia Pacific Non-Hodgkin lymphoma treatment Market
  • 9.5. Latin America Non-Hodgkin lymphoma treatment Market Snapshot
    • 9.5.1. Brazil Non-Hodgkin lymphoma treatment Market
    • 9.5.2. Mexico Non-Hodgkin lymphoma treatment Market
  • 9.6. Rest of The World Non-Hodgkin lymphoma treatment Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Takeda Pharmaceutical Company Limited
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. AstraZeneca plc
    • 10.2.3. Bayer AG
    • 10.2.4. Novartis AG
    • 10.2.5. Kyowa Kirin Co. Ltd.
    • 10.2.6. Bristol Myers Squibb Company
    • 10.2.7. Janssen Pharmaceuticals Inc.
    • 10.2.8. Merck & Co. Inc.
    • 10.2.9. Sanofi India
    • 10.2.10. AbbVie. Inc

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Non-Hodgkin lymphoma treatment Market, report scope
  • TABLE 2. Global Non-Hodgkin lymphoma treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Non-Hodgkin lymphoma treatment Market estimates & forecasts by Therapy 2019-2029 (USD Billion)
  • TABLE 4. Global Non-Hodgkin lymphoma treatment Market estimates & forecasts by Disease type 2019-2029 (USD Billion)
  • TABLE 5. Global Non-Hodgkin lymphoma treatment Market estimates & forecasts by Distribution channel 2019-2029 (USD Billion)
  • TABLE 6. Global Non-Hodgkin lymphoma treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Non-Hodgkin lymphoma treatment Market by Region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Non-Hodgkin lymphoma treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Non-Hodgkin lymphoma treatment Market by Region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Non-Hodgkin lymphoma treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Non-Hodgkin lymphoma treatment Market by Region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Non-Hodgkin lymphoma treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Non-Hodgkin lymphoma treatment Market by Region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Non-Hodgkin lymphoma treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Non-Hodgkin lymphoma treatment Market by Region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Non-Hodgkin lymphoma treatment Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Non-Hodgkin lymphoma treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Non-Hodgkin lymphoma treatment Market
  • TABLE 71. List of primary sources, used in the study of global Non-Hodgkin lymphoma treatment Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Non-Hodgkin lymphoma treatment Market, research methodology
  • FIG 2. Global Non-Hodgkin lymphoma treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Non-Hodgkin lymphoma treatment Market, key trends 2021
  • FIG 5. Global Non-Hodgkin lymphoma treatment Market, growth prospects 2022-2029
  • FIG 6. Global Non-Hodgkin lymphoma treatment Market, porters 5 force model
  • FIG 7. Global Non-Hodgkin lymphoma treatment Market, pest analysis
  • FIG 8. Global Non-Hodgkin lymphoma treatment Market, value chain analysis
  • FIG 9. Global Non-Hodgkin lymphoma treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Non-Hodgkin lymphoma treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Non-Hodgkin lymphoma treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Non-Hodgkin lymphoma treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Non-Hodgkin lymphoma treatment Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Non-Hodgkin lymphoma treatment Market, Regional snapshot 2019 & 2029
  • FIG 15. North America Non-Hodgkin lymphoma treatment Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Non-Hodgkin lymphoma treatment Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Non-Hodgkin lymphoma treatment Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Non-Hodgkin lymphoma treatment Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Non-Hodgkin lymphoma treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable